Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$7.90 +0.40 (+5.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Maravai Lifesciences Holdings (MRVI) Return on Sales [ROS] (2020 - 2026)

Updated

Maravai Lifesciences Holdings (MRVI) posted Return on Sales [ROS] of -29.33% for Q2 2026, up 110.50 percentage points from -139.84% a year earlier but down 26.05 percentage points from the prior quarter.

Analysis

Maravai Lifesciences Holdings (MRVI) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Maravai Lifesciences Holdings was -56.08%, up 88.92 percentage points year-over-year; for FY2025, it came in at -115.89%, down 24.99 percentage points from FY2024.

  • Annual Return on Sales [ROS] has declined for four consecutive years, with a five-year change of -158.10 percentage points (FY2020 to FY2025).
  • In prior years, Maravai Lifesciences Holdings' Return on Sales [ROS] was -90.91% in FY2024 (-79.95 pp), -10.95% in FY2023 (-75.98 pp), 65.03% in FY2022 (-4.37 pp) and 69.40% in FY2021 (+27.19 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -239.93% in Q3 2024 to a high of 75.87% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -20.95 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2025, with a gain of 141.37 percentage points; the weakest was Q3 2024, with a drop of 216.88 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -3.28% (Q1 2026), -117.91% (Q4 2025) and -98.56% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 Maravai Lifesciences Holdings 2.05 Bn 1.51 Bn 20.65 Mn -29.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.33%
Mar 31, 2026 -3.28%
Dec 31, 2025 -117.91%
Sep 30, 2025 -98.56%
Jun 30, 2025 -139.84%
Mar 31, 2025 -104.93%
Dec 31, 2024 -66.66%
Sep 30, 2024 -239.93%
Jun 30, 2024 -19.36%
Mar 31, 2024 -29.39%
Dec 31, 2023 -9.64%
Sep 30, 2023 -23.06%
Jun 30, 2023 -16.85%
Mar 31, 2023 3.21%
Dec 31, 2022 53.37%
Sep 30, 2022 61.12%
Jun 30, 2022 74.44%
Mar 31, 2022 68.51%
Dec 31, 2021 67.65%
Sep 30, 2021 75.87%
API Access

Maravai Lifesciences Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MRVI&period=max&api_key=YOUR_API_KEY